Details

NameSymbolSector
JENBURKT PHARMACEUTICALS LTD.JENBURPHPharmaceuticals
Open
942
High
952.45
Low
916.05
Close
916.05
Volume
243
Exchange
bse
Time
16-Oct-2026

Outlook

Score:  

4.25

Rating:  

FAIR

Candlestick Pattern

Candle pattern of Jenburkt Pharmaceuticals is  
None
Estimated Stoploss of Jenburkt Pharmaceuticals is ₹  
952.45
Jenburkt Pharmaceuticals has a  
Bearishℹ
 pattern. 
Formation of  
None
 candle pattern indicates the trend direction of Jenburkt Pharmaceuticals is  
Unpredictableℹ
. 

Trend

Jenburkt Pharmaceuticals is in  
Sideways trendℹ
. 
Price of Jenburkt Pharmaceuticals is  
Downℹ
 by  

8.18

%. 
Target
Buy @ 

894.34

Sell @ 

1173.74

Current @ 

916.05

Volume

The trade volumes of Jenburkt Pharmaceuticals have become  
Deficientℹ
The volume trend for Jenburkt Pharmaceuticals is  
Bearishℹ
, but the participants are  
Weak Sellersℹ
The trade volume of Jenburkt Pharmaceuticals is  

Down

 by  

76.28

% 

Valuation

The current market price of Jenburkt Pharmaceuticals is  
Fairℹ

Financials

Balance
With total liablities and shareholder equity worth ₹ 196cr and total assets worth ₹ 196cr, the balance sheet of Jenburkt Pharmaceuticals is:  
Balancedℹ
. 
Cashflow
Jenburkt Pharmaceuticals has  
Sufficientℹ
 cash flow because there is  

Surplus

 of  

₹ 3cr

. It is  
Upℹ
 by  

0

%. 

(*Mar 2025)

52.94% i.e. ₹ 27cr earned in operatingℹ
33.33% i.e. ₹ 17cr spent in investingℹ
13.73% i.e. ₹ 7cr spent in financingℹ
0% in otherℹ
Jenburkt Pharmaceuticals has  
Insufficientℹ
 cash flow because it is  

₹ 0cr

. It is  
Upℹ
 by  

100

%. 

(*Mar 2024)

53.33% i.e. ₹ 8cr earned in operatingℹ
0% in investingℹ
46.67% i.e. ₹ 7cr spent in financingℹ
0% in otherℹ
Income
The income of Jenburkt Pharmaceuticals is  

₹ 47cr

 and  

Profit

 is :  

₹ 10cr

(*Sep 2025)

Jenburkt Pharmaceuticals Profit is up by:  

42.86

% and Income is Up by:  

27.03

% 

(*Sep 2025)

The income of Jenburkt Pharmaceuticals is  

₹ 37cr

 and  

Profit

 is :  

₹ 7cr

(*Jun 2025)

Jenburkt Pharmaceuticals Profit is down by:  

12.5

% and Income is Down by:  

11.9

% 

(*Jun 2025)

The income of Jenburkt Pharmaceuticals is  

₹ 42cr

 and  

Profit

 is :  

₹ 8cr

(*Mar 2025)

Jenburkt Pharmaceuticals Profit is up by:  

33.33

% and Income is Up by:  

10.53

% 

(*Mar 2025)

By using this site you agree to the use of cookies to deliver a better site experience.